BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 2481981)

  • 1. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
    Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
    Thor P; Laskiewicz J; Konturek P; Konturek SJ
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
    Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagal stimulation on pancreatic secretion and on blood levels of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide, and somatostatin.
    Guzman S; Chayvialle JA; Banks WA; Rayford PL; Thompson JC
    Surgery; 1979 Aug; 86(2):329-36. PubMed ID: 462378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
    Li P; Lee KY; Chang TM; Chey WY
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural mechanisms of pancreatic polypeptide release in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; Rayford PL
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G134-7. PubMed ID: 2568754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
    Kuvshinoff BW; Brodish RJ; Fink AS; McFadden DW
    J Surg Res; 1994 May; 56(5):397-401. PubMed ID: 8170138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R; Chowdhury P; Rayford PL
    Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
    Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
    Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs.
    Hosotani R; Chowdhury P; McKay D; Rayford PL
    Peptides; 1987; 8(6):1061-4. PubMed ID: 3441445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
    Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas.
    He X; Nelson MT; Debas HT
    Chin Med Sci J; 1996 Mar; 11(1):32-5. PubMed ID: 9206116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholecystokinin in pancreatic bicarbonate secretion in dogs.
    Jo YH; Lee KY; Chang TM; Chey WY
    Pancreas; 1991 Mar; 6(2):197-201. PubMed ID: 1886888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.